Exchange: NASDAQ·Updated 07:57 PM EST
KOD logo

KOD Kodiak Sciences Inc

$97.17
$0.73
(0.75%)
Today
Closed $97.17
$0.09
(0.09%)
After Hours
Reported EarningsNov 12
Mkt Cap$6.35B
Vol693,119.00

About KOD

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
59

Bullish Sentiment

How do you feel about KOD?

savagehenry1
$KOD the weirdest thing about this stock is the fundamentals suck *and* there’s no hype after the initial 175% run up. On paper, it really is the perfect short. It’s protected though, through manipulation. Bulls, you better hope your MM mommy & daddy protect you forever, because the minute they leave you home alone, us bears are coming in. And we’re gonna rip you apart.
1
4
savagehenry1
$KOD Well, thank goodness we have this rock-solid store of value amid the broader market carnage: a pre revenue biotech up nearly 200% in a month, with no approved product, no established commercial business, a deeply speculative valuation, and some remarkably “influential” shareholders. Don’t you just love how fundamentals are optional when price support is the business model?
4
GZ4kdd
$KOD 0 revenue, 0 product, dilution + cash burn, delays, with complete speculation at $100 😂vs $OTLK with current FDA approval and revenue, trading in the pennies, what is going on
1
3
Cutlass
$KOD Shorty needs 9M shares soon - should be able to find them over 105 per our tracking. He certainly has been slowly buying and keeping KOD over 80.00 Tick Tock - ⏰✍️👀
1
3
Stekli27
$KOD Hey shorties, how does it feel seeing us trending after hours? 🤡 Baker Bros reportedly added another $24M around $98.51. I bought back at $92–98. Nice company to be in. How’s your weekend looking, shorties? 🤡
1
2
Cutlass
$KOD Trimmed a bit more for YTD Gains - but holding some shares in three accounts for runners ✅ I got mine Bears, how you doing?
5
Hankies
$KOD The ATM is likely running at these prices above 90. They need cash now. Unreal this never dropped as the manipulation continues. No position here but while selling volumes seem low, so is the buying. I'm not sure what the incentive to buy here is. The price IMO has baked in more than the oven can hold, which will eventually spill/burn/dilute. Still intersting to watch how one fund company can control a low volume stock so long.
5
AgentBlack
$KOD lol, according to Victor, the 6 month durability is “It’s not predictable exactly” ... i thought thats one of the key drivers for the rerate. 😆😆
4
Hankies
$KOD Don't worry, this will be manipulated back to new highs today. When will reality hit this stock?
4
MagicRon_
$KOD My prediction is they will have a clear beat and then announce the offering within days 👎🐻
4
AgentBlack
$KOD pretty good as just before that it crashed from 102 to 90. Bulls in this chat have short memories.
1
1
AgentBlack
$KOD such a tough market to call at the moment. Hit target yesterday but was very dicey when it started going back up mid day. Cautiously observing now.
1
1
Stekli27
$KOD 100✅ Remember $REGN dropping after the DAYBREAK readout? Look at it now. Today’s results show why there’s still plenty of opportunity in retinal treatments. Kodiak has two more catalysts ahead and, if the data delivers, potential for a blockbuster. Still a long, bumpy road, but we’re in a much better position than when we were buying around $1.80 three years ago. Honestly, I’m glad retail overlooked this one. I’d rather follow clinical progress than another overhyped biotech ticker with millions of shares traded and endless 🚀 posts every day. Let’s see what the next two readouts bring. Bears might need some new material 😜
4
savagehenry1
$KOD $KOD I really hope this is decoupled from the larger market trend right now. I don’t want to see this rocket back up when things go green. Based on a whole lot of metrics, this thing deserves to correct big time. It has been a manipulation fest, all at the expense of common sense bears. I remain short until $55.
3
BiotechSwings
$KOD has a December clock nobody is treating like a binary yet PEAK Phase 3, KSI 101 in macular edema secondary to inflammation, first 300 patient cohort enrolled, topline next month if it hits, the company plan is a BLA filing in the second quarter of 2027 trading 110.48 today, up 2.06% and up 21.38% in five sessions, right under the 112.31 high from Nov 11 imo
3
pirates4life
$KOD Notice how when the price was above $80, the market makers, whales, and institutional investors made the stock go sideways for a whole year before plummeting down to true price. That means they could easily make this POS go a year before retail gets tired of holding and sells their buy and short position for a loss. KOD you’re not fooling anyone. Your company has 0 active products on the market and still under “trial”
3
F14TOMCATIIAF
$KOD This is my final post about $KOD. To everyone holding long positions and hoping for the price to rise: you have far less time to exit than you might think. best of luck to you.
3
IchthysTrades
is it true that $KOD patients still have to go to the doctor for monthly checks through their ai system, keeping a monthly burden on the patient, the Dr, and the payer? $OCUL doesn’t require this, do they?
2
Stekli27
$KOD Victor sounded confident at UBS, especially on MESI and KSI-101. If the upcoming data deliver, Kodiak could build a multibillion-dollar retinal franchise, with further upside from the ABC platform. Financing and dilution remain risks, but raising capital can also fund the next stage of growth. Holding into the readout. Shorts, Christmas could get interesting 😉🎄
2

Advertisement|Remove ads.